Multiple sclerosis affects about 400,000 Americans annually. This condition is the result of the protective lining that surrounds and protects the neurons of the cells, called myelin, being attacked by the immune system. Without myelin, patients of MS feel weak and may have difficulty walking and moving around. This is a debilitating illness that people [Read More]
BrainStorm Cell Therapeutics have received approval from the United States Food and Drug Administration to proceed with Phase 2 trials for their stem cell treatment for progressive multiple sclerosis (1). The treatment utilizes a proprietary autologous stem cell treatment, injecting patient-derived mesenchymal stem cells that secrete neurotrophic factors to stem the advance of disease (2). [Read More]
The results of new research indicate that a treatment involving transplantation of stem cells could change the face of multiple sclerosis treatments. The patient’s immune system is first wiped out with anti-cancer medications. Following this, a new immune system is developed with the help of a stem cell transplant. One patient, age 36, says the [Read More]
Caroline Wyatt, a 49-year-old journalist with the British Broadcasting Corporation, has spoken about how a pioneering stem cell treatment has helped lift the brain fog associated with her multiple sclerosis. She says she hasn’t felt this good in a long time. Wyatt’s MS was diagnosed after more than two decades of seeing doctors for unexplained [Read More]
People from all around the world are flocking to Moscow, Russia, for innovative stem cell therapies for MS. Multiple sclerosis is a crippling disease that affects the brain and spinal cord. MS is an autoimmune disease that is unpredictable and affects different people in different ways. Clinical management and pharmacotherapy can help relieve symptoms and [Read More]
In what is being hailed as a remarkable success, doctors at Ottawa Hospital have used stem cell treatment and succeeded in reversing the effects of the disease in patients with severe MS (multiple sclerosis). MS is a crippling disease more common in females and more prevalent in temperate climates such as Canada and the United [Read More]
Recent results from a phase 2 clinical trial using stem cell transplantation have offered new hope for the treatment of aggressive multiple sclerosis. Multiple sclerosis (MS), while not a deadly disease, is known as severely debilitating, slowly deteriorating a patient’s entire nervous system. An aggressive form of MS rapidly results in failure of the nerves [Read More]
About 2.5 million people around the world and 400,000 Americans are affected by multiple sclerosis (MS), a disabling disease of the nervous system in which the body’s immune system attacks the protective myelin sheath that covers nerves. This leads to gaps in communication between the brain and various parts of the body. In advanced cases, [Read More]
